Idiopathic pulmonary fibrosis: idiopathic no more?

The Lancet Respiratory Medicine

Volumn 6, Issue 2, 2018, Pages 84-85

  Thannickal, Victor J ^a   Wells, Athol ^b   Kolb, Martin ^c  

^a and Clinical Center   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER; MUCIN;

AGING; ALLELE; ASBESTOSIS; AUTOIMMUNE DISEASE; CELL DAMAGE; CONNECTIVE TISSUE DISEASE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE EXACERBATION; DRUG EXPOSURE; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROSING ALVEOLITIS; GENE; GENE INTERACTION; GENE LOCUS; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HISTOPATHOLOGY; IMMUNE RESPONSE; INFLAMMATORY CELL; INTERSTITIAL PNEUMONIA; LIFESTYLE; LUNG EPITHELIUM; LUNG FIBROSIS; MUC5B GENE; NOTE; OCCUPATIONAL EXPOSURE; ONSET AGE; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; RISK ASSESSMENT; RISK FACTOR; SCAR FORMATION; SMOKING; SURVIVAL; TRANSCRIPTOMICS; USUAL INTERSTITIAL PNEUMONIA; HUMAN;

HUMANS; IDIOPATHIC PULMONARY FIBROSIS; PULMONARY FIBROSIS;

EID: 85041228244     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(18)30022-5     Document Type: Note

References (10)

1. Raghu, G, Collard, HR, Egan, JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183 (2011), 788–824.
2. Wolters, PJ, Blackwell, TS, Eickelberg, O, et al. Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?. Lancet Respir Med 6 (2018), 154–160.
3. Boyle, EA, Li, YI, Pritchard, JK, An expanded view of complex traits: from polygenic to omnigenic. Cell 169 (2017), 1177–1186.
4. Fingerlin, TE, Murphy, E, Zhang, W, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet 45 (2013), 613–620.
5. Evans, CM, Fingerlin, TE, Schwarz, MI, et al. Idiopathic pulmonary fibrosis: a genetic disease that involves mucociliary dysfunction of the peripheral airways. Physiol Rev 96 (2016), 1567–1591.
6. Thannickal, VJ, Zhou, Y, Gaggar, A, Duncan, SR, Fibrosis: ultimate and proximate causes. J Clin Invest 124 (2014), 4673–4677.
7. Seddon, JM, Reynolds, R, Maller, J, Fagerness, JA, Daly, MJ, Rosner, B, Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci 50 (2009), 2044–2053.
8. Jostins, L, Barrett, JC, Genetic risk prediction in complex disease. Hum Mol Genet 20 (2011), R182–R188.
9. Zhou, Y, Huang, X, Hecker, L, et al. Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. J Clin Invest 123 (2013), 1096–1108.
10. Feghali-Bostwick, CA, Tsai, CG, Valentine, VG, et al. Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis. J Immunol 179 (2007), 2592–2599.